GlassScriptPhysician profile
Lisa Amsterdam
NPI 1770568925
$1,841.23
in general payments reported to CMS, 2019-2025
28 companies · $435 in 2025
The $435 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $97.34 · 2021: $36.24 · 2022: $185 · 2023: $320 · 2024: $343 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $322.43 | 2019-2025 | Lo Loestrin Fe, Ubrelvy |
| Biogen, INC. | $253.90 | 2024-2025 | Zurzuvae |
| Organon LLC | $117.75 | 2022-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $101.28 | 2023-2024 | Myfembree |
| Astellas Pharma US INC | $93.40 | 2023-2024 | Veozah |
| Daiichi Sankyo INC. | $92.71 | 2019-2022 | |
| Hologic Sales and Service, LLC | $77.10 | 2019-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Coopersurgical, INC. | $71.98 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $68.66 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $68.56 | 2024-2025 | |
| Gynesonics, INC. | $60.75 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Allergan, INC. | $55.90 | 2019 | |
| Agile Therapeutics, INC. | $54.56 | 2022-2024 | Twirla |
| Exeltis, USA INC. | $48.90 | 2019-2025 | Slynd |
| Lupin INC. | $44.82 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $40.10 | 2024-2025 | Intrarosa, Femring |
| Olympus America INC. | $36.73 | 2023-2025 | Olympus |
| Covidien LP | $31.93 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.91 | 2019-2024 | |
| Amag Pharmaceuticals, INC. | $29.54 | 2019 | |
| Minerva Surgical, INC | $27.90 | 2019-2020 | |
| Medtronic, INC. | $24.27 | 2023 | Ligasure |
| Scynexis, INC. | $22.97 | 2022 | |
| Avion Pharmaceuticals | $13.55 | 2021 | |
| Merck Sharp & Dohme LLC | $13.28 | 2020 | |
| Baxter Healthcare | $12.79 | 2023 | Perclot |
| Therapeuticsmd, INC. | $11.92 | 2022 | |
| Channel Medsystems, INC. | $11.64 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Amsterdam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.